Neurosant Therapeutics

Neurosant treats neurologic disease such as Smith-Magenis Syndrome caused by loss of dosage-sensitive genes, untreatable by current gene therapy technologies.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location San Diego, CA, USA
  • Currency USD
  • Founded February 2020
  • Employees 1
  • Incorporation Type Not Incorporated

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free